HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Young-Ran Lee Selected Research

Histocompatibility Antigens Class I

10/2022Efficient Anti-Tumor Immunotherapy Using Tumor Epitope-Coated Biodegradable Nanoparticles Combined With Polyinosinic-Polycytidylic Acid and an Anti-PD1 Monoclonal Antibody.
12/2021Induction of Peptide-specific CTL Activity and Inhibition of Tumor Growth Following Immunization with Nanoparticles Coated with Tumor Peptide-MHC-I Complexes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Young-Ran Lee Research Topics

Disease

8Neoplasms (Cancer)
10/2022 - 01/2011
2Carcinoma (Carcinomatosis)
08/2014 - 01/2014
2Melanoma (Melanoma, Malignant)
03/2014 - 01/2011
1Inflammation (Inflammations)
02/2022
1Anthrax
01/2021
1Smallpox (Variola)
01/2021
1Body Weight Changes
12/2017
1Body Weight (Weight, Body)
12/2017
1Colitis
03/2017
1Alopecia (Baldness)
07/2016
1Colonic Neoplasms (Colon Cancer)
08/2014
1Infections
04/2013
1Obesity
09/2009
1Insulin Resistance
09/2009
1Type 2 Diabetes Mellitus (MODY)
09/2009
1Hypotrichosis
11/2006

Drug/Important Bio-Agent (IBA)

4VaccinesIBA
12/2021 - 01/2011
3Peptides (Polypeptides)IBA
10/2022 - 04/2013
3EpitopesIBA
10/2022 - 03/2014
2Monoclonal AntibodiesIBA
10/2022 - 03/2014
2Histocompatibility Antigens Class IIBA
10/2022 - 12/2021
2Poly I-CIBA
10/2022 - 03/2014
2Polylactic Acid-Polyglycolic Acid CopolymerIBA
10/2022 - 12/2021
2AntigensIBA
01/2021 - 03/2014
2Hypoglycemic Agents (Hypoglycemics)IBA
12/2017 - 09/2009
2Blood Glucose (Blood Sugar)IBA
12/2017 - 09/2009
1ethyleneIBA
10/2022
1Maleic Anhydrides (Maleic Anhydride)IBA
10/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
02/2022
1PolymersIBA
12/2021
1Combined VaccinesIBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
12/2017
1Streptozocin (Streptozotocin)FDA Link
12/2017
1Interleukin-6 (Interleukin 6)IBA
03/2017
1Dextran SulfateIBA
03/2017
1PowdersIBA
03/2017
1Biomarkers (Surrogate Marker)IBA
03/2017
1Paclitaxel (Taxol)FDA LinkGeneric
08/2014
1baccatin IIIIBA
08/2014
1LigandsIBA
03/2014
1B7-H1 AntigenIBA
03/2014
1Cancer VaccinesIBA
03/2014
1resiquimodIBA
01/2014
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
04/2013
1Subunit VaccinesIBA
04/2013
1AntibodiesIBA
04/2013
1CPG-oligonucleotideIBA
02/2013
1Protein Subunit VaccinesIBA
01/2011
1CytokinesIBA
01/2011
1InterferonsIBA
01/2011
1Aloe vera gelIBA
09/2009

Therapy/Procedure

3Immunotherapy
10/2022 - 01/2014
3Oral Administration
03/2017 - 09/2009
3Therapeutics
08/2014 - 04/2013
2Transplantation
07/2016 - 11/2006
1Intravenous Administration
12/2021